Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HTL.V Relative to the S&P 500

HTL.V Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Hamilton Thorne Ltd. (TSXV:HTL.V) seasonal charts above shows that a Buy Date of December 22 and a Sell Date of May 12 has resulted in a geometric average return of 33.5% above the benchmark rate of the S&P 500 Total Return Index over the past 15 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 15 years by an average of 37.63% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors. The company’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has single reporting segment being Engaged in Sales to the ART, Research and Cell Biology Markets.

To download HTL.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HTL.V